Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.475 USD | +2.51% | -7.73% | -35.33% |
May. 07 | Transcript : Harvard Bioscience, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 Revenue $24.5M | MT |
Financials (USD)
Sales 2024 * | 112M | Sales 2025 * | 124M | Capitalization | 147M |
---|---|---|---|---|---|
Net income 2024 * | -3M | Net income 2025 * | 3M | EV / Sales 2024 * | 1.32 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.19 x |
P/E ratio 2024 * |
-42.4
x | P/E ratio 2025 * |
45.2
x | Employees | 404 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.72% |
Latest transcript on Harvard Bioscience, Inc.
1 day | -3.97% | ||
1 week | -13.52% | ||
Current month | -11.26% | ||
1 month | -20.05% | ||
3 months | -22.25% | ||
6 months | -17.11% | ||
Current year | -36.64% |
Managers | Title | Age | Since |
---|---|---|---|
James Green
CEO | Chief Executive Officer | 65 | 15-04-27 |
Jennifer Cote
DFI | Director of Finance/CFO | 52 | 22-04-30 |
David Balcom
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
James Green
CEO | Chief Executive Officer | 65 | 15-04-27 |
Alan Edrick
BRD | Director/Board Member | 56 | 19-09-02 |
Bertrand Loy
BRD | Director/Board Member | 58 | 14-11-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.37% | 4 M€ | -5.15% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +3.39% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 3.46 | +2.06% | 66 347 |
24-05-13 | 3.39 | -3.97% | 80,885 |
24-05-10 | 3.53 | -0.84% | 69,177 |
24-05-09 | 3.56 | -3.26% | 115,411 |
24-05-08 | 3.68 | -1.87% | 85,633 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.64% | 147M | |
+11.29% | 225B | |
+8.76% | 186B | |
+12.90% | 135B | |
+25.95% | 107B | |
+0.34% | 63.56B | |
+11.08% | 51.04B | |
+5.62% | 51.32B | |
+6.28% | 43.3B | |
+4.80% | 36.99B |
- Stock Market
- Equities
- HBIO Stock